Skip to content

DERMISEA SRL: what changed

BE 0754.817.277NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€105,353
2024 · €99,873+€5,480
Equity
€185,280
2024 · €185,280
Cash
€272,735
2024 · €257,178+€15,556
Balance sheet total
€299,246
2024 · €295,037+€4,209

Largest movements

2024 to 2025
Assets
  • Cash +€15,556

    up €15,556 (+6.0%), from €257,178 to €272,735

    mainly Net result for the year (+€105,353) and Deferred charges and accrued income (+€15,378)

  • Deferred charges and accrued income -€15,378

    down €15,378 (-52.3%), from €29,398 to €14,020

  • Receivables within one year +€5,416

    up €5,416 (+78.9%), from €6,866 to €12,282

Equity and liabilities
  • Other debts +€3,476

    up €3,476 (+3.3%), from €105,274 to €108,751

Income statement
  • Depreciation -€5,112

    down €5,112 (-78.7%), from €6,497 to €1,385

  • Gross operating margin +€1,586

    up €1,586 (+1.2%), from €135,784 to €137,369

  • Taxes +€1,450

    up €1,450 (+5.2%), from €28,134 to €29,584

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €99,873
Gross operating margin +€1,586
Depreciation +€5,112
Other operating charges +€232
Financial income -€0
Taxes -€1,450
Result 2025 €105,353
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€120,909
Investment €0
Financing -€105,353
Cash 2024 €257,178
Net result for the year +€105,353
Depreciation +€1,385
Receivables within one year -€5,416
Deferred charges and accrued income +€15,378
Smaller working-capital items -€257
Other debts +€3,476
Accrued charges and deferred income +€990
Contributions, distributions and other -€105,353
Cash 2025 €272,735
brings cash intakes cash out
Every line side by side 35 lines
Line Code 2024 2025 Change %
Total assets 20/58 €295,037 €299,246 +€4,209 +1.4%
Formation expenses 20 €506 - -€506
Fixed assets 21/28 €1,088 €210 -€878 -80.7%
Tangible fixed assets 22/27 €1,088 €210 -€878 -80.7%
Furniture and vehicles 24 €1,088 €210 -€878 -80.7%
Current assets 29/58 €293,443 €299,037 +€5,594 +1.9%
Amounts receivable within one year 40/41 €6,866 €12,282 +€5,416 +78.9%
Other amounts receivable 41 €6,866 €12,282 +€5,416 +78.9%
Cash at bank and in hand 54/58 €257,178 €272,735 +€15,556 +6.0%
Deferred charges and accrued income 490/1 €29,398 €14,020 -€15,378 -52.3%
Total equity and liabilities 10/49 €295,037 €299,246 +€4,209 +1.4%
Equity 10/15 €185,280 €185,280 = 0.0%
Contributions 10/11 €5,000 €5,000 = 0.0%
Reserves 13 €180,280 €180,280 = 0.0%
Distributable reserves 133 €180,280 €180,280 = 0.0%
Amounts payable 17/49 €109,757 €113,966 +€4,209 +3.8%
Amounts payable within one year 42/48 €109,757 €112,976 +€3,219 +2.9%
Trade debts 44 €1,178 €1,034 -€144 -12.3%
Suppliers 440/4 €1,178 €1,034 -€144 -12.3%
Taxes, remuneration and social security 45 €3,305 €3,192 -€113 -3.4%
Taxes 450/3 €3,305 €3,192 -€113 -3.4%
Other amounts payable 47/48 €105,274 €108,751 +€3,476 +3.3%
Accrued charges and deferred income 492/3 - €990 +€990
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €6,497 €1,385 -€5,112 -78.7%
Other operating charges 640/8 €1,176 €943 -€232 -19.8%
Gross operating margin 9900 €135,784 €137,369 +€1,586 +1.2%
Operating profit (loss) 9901 €128,111 €135,041 +€6,930 +5.4%
Financial income 75/76B €0 - -€0
Recurring financial income 75 €0 - -€0
Financial charges 65/66B €104 €104 = 0.0%
Recurring financial charges 65 €104 €104 = 0.0%
Profit (loss) for the period before taxes 9903 €128,007 €134,937 +€6,930 +5.4%
Income taxes 67/77 €28,134 €29,584 +€1,450 +5.2%
Profit (loss) for the period 9904 €99,873 €105,353 +€5,480 +5.5%
Profit (loss) for the period to be appropriated 9905 €99,873 €105,353 +€5,480 +5.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€376,786 to €490,445

Midpoint €424,144 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €185,280
Capitalised earnings €568,293 to €795,610
Indication €376,786 to €490,445

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€185,280
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€185,280

Capitalised earnings

net result for the year (9904)
2025
€105,353
2024
€99,873
2023
€33,457
2022
€93,364
2021
€53,458
Average result
€79,561
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€568,293 / €663,008 / €795,610

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.